Published in Medical Devices and Surgical Technology Week, July 2nd, 2006
Specifically configured for cardiac PET, SceptreC allows the utilization of both Rubidium-82 for myocardial perfusion and 18-FDG for myocardial viability procedures.
"Whole-body PET/CT [computed tomography] offers significant throughput advantages for oncology," stated Raymond Wtulich, PET & PET/CT product manager for HMSA. "However, in cardiac imaging only one bed position is required for a stress or rest acquisition making dedicated PET a comparable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.